Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., et al.: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med., 2001, 29, 1303–1310.

Lidicker J. , 'Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care ' (2001 ) 29 Crit. Care Med. : 1303 -1310.

Lidicker J.Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of careCrit. Care Med.20012913031310)| false
• Search Google Scholar

Fry, A., Shay, D. K., Holman, R. C., et al.: Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002. JAMA, 2005, 294, 2712–2719.

Holman R. C. , 'Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002 ' (2005 ) 294 JAMA : 2712 -2719.

Holman R. C.Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002JAMA200529427122719)| false
• Search Google Scholar

Metlay, J. P., Fishman, N. O., Joffe, M., et al.: Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine, 2006, 24, 468–475.

Joffe M. , 'Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults ' (2006 ) 24 Vaccine : 468 -475.

Joffe M.Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adultsVaccine200624468475)| false
• Search Google Scholar

Venkatesh, B., Kennedy, P., Kruger, P. S., et al.: Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation. Anaesth. Intensive Care, 2009, 37, 20–26.

Kruger P. S. , 'Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation ' (2009 ) 37 Anaesth. Intensive Care : 20 -26.

Kruger P. S.Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluationAnaesth. Intensive Care2009372026)| false
• Search Google Scholar

Socan, M.: Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course. J. Chemother., 1998, 10, 64–68.

Socan M. , 'Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course ' (1998 ) 10 J. Chemother. : 64 -68.

Socan M.Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day courseJ. Chemother.1998106468)| false
• Search Google Scholar

Johnstone, J., Eurich, D. T., Majumdar, S. R., et al.: Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore), 2008, 87, 329–334.

Majumdar S. R. , 'Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study ' (2008 ) 87 Medicine (Baltimore) : 329 -334.

Majumdar S. R.Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort studyMedicine (Baltimore)200887329334)| false
• Search Google Scholar

Fine, M. J., Auble, T. E., Yealy, D. M., et al.: A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med., 1997, 336, 243–250.

Yealy D. M. , 'A prediction rule to identify low-risk patients with community-acquired pneumonia ' (1997 ) 336 N. Engl. J. Med. : 243 -250.

Yealy D. M.A prediction rule to identify low-risk patients with community-acquired pneumoniaN. Engl. J. Med.1997336243250)| false
• Search Google Scholar

Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., et al.: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet, 2004, 363, 600–607.

Bingisser R. , 'Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial ' (2004 ) 363 Lancet : 600 -607.

Bingisser R.Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trialLancet2004363600607)| false
• Search Google Scholar

Kruger, S., Ewig, S., Marre, R., et al.: Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur. Respir. J., 2008, 31, 349–355.

Marre R. , 'Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes ' (2008 ) 31 Eur. Respir. J. : 349 -355.

Marre R.Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classesEur. Respir. J.200831349355)| false
• Search Google Scholar

Christ-Crain, M., Stolz, D., Bingisser, R., et al.: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med., 2006, 174, 84–93.

Bingisser R. , 'Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial ' (2006 ) 174 Am. J. Respir. Crit. Care Med. : 84 -93.

Bingisser R.Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trialAm. J. Respir. Crit. Care Med.20061748493)| false
• Search Google Scholar

Dunbar, L. M., Wunderink, R. G., Habib, M. P., et al.: High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin. Infect. Dis., 2003, 37, 752–760.

Habib M. P. , 'High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm ' (2003 ) 37 Clin. Infect. Dis. : 752 -760.

Habib M. P.High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigmClin. Infect. Dis.200337752760)| false
• Search Google Scholar

Shorr, A. F., Zadeikis, N., Xiang, J. X., et al.: A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumonia. Clin. Ther., 2005, 27, 1251–1259.

Xiang J. X. , 'A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumonia ' (2005 ) 27 Clin. Ther. : 1251 -1259.

Xiang J. X.A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community-acquired pneumoniaClin. Ther.20052712511259)| false
• Search Google Scholar

Lee, R. W., Lindstrom, S. T.: Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia. Respirology, 2007, 12, 111–116.

Lindstrom S. T. , 'Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia ' (2007 ) 12 Respirology : 111 -116.

Lindstrom S. T.Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumoniaRespirology200712111116)| false
• Search Google Scholar

Omidvari, K., de Boisblanc, B. P., Karam, G., et al.: Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis. Respir. Med., 1998, 92, 1032–1039.

Karam G. , 'Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis ' (1998 ) 92 Respir. Med. : 1032 -1039.

Karam G.Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysisRespir. Med.19989210321039)| false
• Search Google Scholar

Don, M., Valent, F., Korppi, M., et al.: Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Scand. J. Infect. Dis., 2007, 39, 129–137.

Korppi M. , 'Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood ' (2007 ) 39 Scand. J. Infect. Dis. : 129 -137.

Korppi M.Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhoodScand. J. Infect. Dis.200739129137)| false
• Search Google Scholar

Huang, D. T., Weissfeld, L. A., Kellum, J. A., et al.: Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann. Emerg. Med., 2008, 52, 48–58. e2.

Kellum J. A. , 'Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia ' (2008 ) 52 Ann. Emerg. Med. : 48 -58. e2.

Kellum J. A.Risk prediction with procalcitonin and clinical rules in community-acquired pneumoniaAnn. Emerg. Med.2008524858. e2)| false
• Search Google Scholar

Menendez, R., Martinez, R., Reyes, S., et al.: Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax, 2009, 64, 587–591.

Reyes S. , 'Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia ' (2009 ) 64 Thorax : 587 -591.

Reyes S.Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumoniaThorax200964587591)| false
• Search Google Scholar

Almirall, J., Bolibar, I., Toran, P., et al.: Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest, 2004, 125, 1335–1342.

Toran P. , 'Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia ' (2004 ) 125 Chest : 1335 -1342.

Toran P.Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumoniaChest200412513351342)| false
• Search Google Scholar

Huang, D. T., Angus, D. C., Kellum, J. A., et al.: Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest, 2009, 136, 823–831.

Kellum J. A. , 'Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia ' (2009 ) 136 Chest : 823 -831.

Kellum J. A.Midregional proadrenomedullin as a prognostic tool in community-acquired pneumoniaChest2009136823831)| false
• Search Google Scholar

Mueller, C., Laule-Kilian, K., Scholer, A., et al.: B-type natriuretic peptide for risk stratification in community-acquired pneumonia. J. Intern. Med., 2005, 258, 391–393.

Scholer A. , 'B-type natriuretic peptide for risk stratification in community-acquired pneumonia ' (2005 ) 258 J. Intern. Med. : 391 -393.

Scholer A.B-type natriuretic peptide for risk stratification in community-acquired pneumoniaJ. Intern. Med.2005258391393)| false
• Search Google Scholar

Moammar, M. Q., Ali, M. I., Mahmood, N. A., et al.: Cardiac troponin I levels and alveolar–arterial oxygen gradient in patients with community-acquired pneumonia. Heart Lung Circ., 2010, 19, 90–92.

Mahmood N. A. , 'Cardiac troponin I levels and alveolar–arterial oxygen gradient in patients with community-acquired pneumonia ' (2010 ) 19 Heart Lung Circ. : 90 -92.

Mahmood N. A.Cardiac troponin I levels and alveolar–arterial oxygen gradient in patients with community-acquired pneumoniaHeart Lung Circ.2010199092)| false
• Search Google Scholar

Kee, C., Palladino, S., Kay, I., et al.: Feasibility of real-time polymerase chain reaction in whole blood to identify Streptococcus pneumoniae in patients with community-acquired pneumonia. Diagn. Microbiol. Infect. Dis., 2008, 61, 72–75.

Kay I. , 'Feasibility of real-time polymerase chain reaction in whole blood to identify Streptococcus pneumoniae in patients with community-acquired pneumonia ' (2008 ) 61 Diagn. Microbiol. Infect. Dis. : 72 -75.

Kay I.Feasibility of real-time polymerase chain reaction in whole blood to identify Streptococcus pneumoniae in patients with community-acquired pneumoniaDiagn. Microbiol. Infect. Dis.2008617275)| false
• Search Google Scholar

Rello, J., Lisboa, T., Lujan, M., et al.: Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest, 2009, 136, 832–840.

Lujan M. , 'Severity of pneumococcal pneumonia associated with genomic bacterial load ' (2009 ) 136 Chest : 832 -840.

Lujan M.Severity of pneumococcal pneumonia associated with genomic bacterial loadChest2009136832840)| false
• Search Google Scholar

Peters, R. P., de Boer, R. F., Schuurman, T., et al.: Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia. J. Clin. Microbiol., 2009, 47, 3308–3312.

Schuurman T. , 'Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia ' (2009 ) 47 J. Clin. Microbiol. : 3308 -3312.

Schuurman T.Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumoniaJ. Clin. Microbiol.20094733083312)| false
• Search Google Scholar

Pines, J. M., Isserman, J. A., Hinfey, P. B.: The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine. J. Emerg. Med., 2009, 37, 335–340.

Hinfey P. B. , 'The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine ' (2009 ) 37 J. Emerg. Med. : 335 -340.

Hinfey P. B.The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency MedicineJ. Emerg. Med.200937335340)| false
• Search Google Scholar

Mortensen, E. M., Coley, C. M., Singer, D. E., et al.: Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch. Intern. Med., 2002, 162, 1059–1064.

Singer D. E. , 'Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study ' (2002 ) 162 Arch. Intern. Med. : 1059 -1064.

Singer D. E.Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort studyArch. Intern. Med.200216210591064)| false
• Search Google Scholar

Koivula, I., Sten, M., Makela, P. H.: Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch. Intern. Med., 1999, 159, 1550–1555.

Makela P. H. , 'Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study ' (1999 ) 159 Arch. Intern. Med. : 1550 -1555.

Makela P. H.Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up studyArch. Intern. Med.199915915501555)| false
• Search Google Scholar

Brancati, F. L., Chow, J. W., Wagener, M. M., et al.: Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia. Lancet, 1993, 342, 30–33.

Wagener M. M. , 'Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumonia ' (1993 ) 342 Lancet : 30 -33.

Wagener M. M.Is pneumonia really the old man’s friend? Two-year prognosis after community-acquired pneumoniaLancet19933423033)| false
• Search Google Scholar

Kaplan, V., Clermont, G., Griffin, M. F., et al.: Pneumonia: still the old man’s friend? Arch. Intern. Med., 2003, 163, 317–323.

Griffin M. F. , 'Pneumonia: still the old man’s friend? ' (2003 ) 163 Arch. Intern. Med. : 317 -323.

Griffin M. F.Pneumonia: still the old man’s friend?Arch. Intern. Med.2003163317323)| false
• Search Google Scholar

Mortensen, E. M., Kapoor, W. N., Chang, C. C., et al.: Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin. Infect. Dis., 2003, 37, 1617–1624.

Chang C. C. , 'Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia ' (2003 ) 37 Clin. Infect. Dis. : 1617 -1624.

Chang C. C.Assessment of mortality after long-term follow-up of patients with community-acquired pneumoniaClin. Infect. Dis.20033716171624)| false
• Search Google Scholar

Madjid, M., Miller, C. C., Zarubaev, V. V., et al.: Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur. Heart J., 2007, 28, 1205–1210.

Zarubaev V. V. , 'Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects ' (2007 ) 28 Eur. Heart J. : 1205 -1210.

Zarubaev V. V.Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjectsEur. Heart J.20072812051210)| false
• Search Google Scholar

Meier, C. R., Jick, S. S., Derby, L. E., et al.: Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet, 1998, 351, 1467–1471.

Derby L. E. , 'Acute respiratory-tract infections and risk of first-time acute myocardial infarction ' (1998 ) 351 Lancet : 1467 -1471.

Derby L. E.Acute respiratory-tract infections and risk of first-time acute myocardial infarctionLancet199835114671471)| false
• Search Google Scholar

Smeeth, L., Thomas, S. L., Hall, A. J., et al.: Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med., 2004, 351, 2611–2618.

Hall A. J. , 'Risk of myocardial infarction and stroke after acute infection or vaccination ' (2004 ) 351 N. Engl. J. Med. : 2611 -2618.

Hall A. J.Risk of myocardial infarction and stroke after acute infection or vaccinationN. Engl. J. Med.200435126112618)| false
• Search Google Scholar

Sakkinen, P., Abbott, R. D., Curb, J. D., et al.: C-reactive protein and myocardial infarction. J. Clin. Epidemiol., 2002, 55, 445–451.

Curb J. D. , 'C-reactive protein and myocardial infarction ' (2002 ) 55 J. Clin. Epidemiol. : 445 -451.

Curb J. D.C-reactive protein and myocardial infarctionJ. Clin. Epidemiol.200255445451)| false
• Search Google Scholar

Park, C. S., Ihm, S. H., Yoo, K. D., et al.: Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA. Am. J. Cardiol., 2010, 105, 1284–1288.

Yoo K. D. , 'Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA ' (2010 ) 105 Am. J. Cardiol. : 1284 -1288.

Yoo K. D.Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USAAm. J. Cardiol.201010512841288)| false
• Search Google Scholar

Yende, S., D’Angelo, G., Kellum, J. A., et al.: Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am. J. Respir. Crit. Care Med., 2008, 177, 1242–1247.

Kellum J. A. , 'Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis ' (2008 ) 177 Am. J. Respir. Crit. Care Med. : 1242 -1247.

Kellum J. A.Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsisAm. J. Respir. Crit. Care Med.200817712421247)| false
• Search Google Scholar

Madjid, M., Vela, D., Khalili-Tabrizi, H., et al.: Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex. Heart Inst. J., 2007, 34, 11–18.

Khalili-Tabrizi H. , 'Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes ' (2007 ) 34 Tex. Heart Inst. J. : 11 -18.

Khalili-Tabrizi H.Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromesTex. Heart Inst. J.2007341118)| false
• Search Google Scholar

Zhang, G., Han, J., Welch, E. J., et al.: Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J. Immunol., 2009, 182, 7997–8004.

Welch E. J. , 'Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway ' (2009 ) 182 J. Immunol. : 7997 -8004.

Welch E. J.Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathwayJ. Immunol.200918279978004)| false
• Search Google Scholar

Puren, A. J., Feldman, C., Savage, N., et al.: Patterns of cytokine expression in community-acquired pneumonia. Chest, 1995, 107, 1342–1349.

Savage N. , 'Patterns of cytokine expression in community-acquired pneumonia ' (1995 ) 107 Chest : 1342 -1349.

Savage N.Patterns of cytokine expression in community-acquired pneumoniaChest199510713421349)| false
• Search Google Scholar

Liu, S. F., Newton, R., Evans, T. W., et al.: Differential regulation of cyclo-oxygenase-I and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin. Sci. (Lond), 1996, 90, 301–306.

Evans T. W. , 'Differential regulation of cyclo-oxygenase-I and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat ' (1996 ) 90 Clin. Sci. (Lond) : 301 -306.

Evans T. W.Differential regulation of cyclo-oxygenase-I and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the ratClin. Sci. (Lond)199690301306)| false
• Search Google Scholar

Blann, A. D.: Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb. Haemost., 2006, 95, 49–55.

Blann A. D. , 'Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years ' (2006 ) 95 Thromb. Haemost. : 49 -55.

Blann A. D.Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 yearsThromb. Haemost.2006954955)| false
• Search Google Scholar

Merx, M. W., Weber, C.: Sepsis and the heart. Circulation, 2007, 116, 793–802.

Weber C. , 'Sepsis and the heart ' (2007 ) 116 Circulation : 793 -802.

Weber C.Sepsis and the heartCirculation2007116793802)| false
• Search Google Scholar

Moammar, M. Q., Ali, M. I., Mahmood, N. A., et al.: Cardiac troponin I levels and alveolar-arterial oxygen gradient in patients with community-acquired pneumonia. Heart Lung Circ., 2010, 19, 90–92.

Mahmood N. A. , 'Cardiac troponin I levels and alveolar-arterial oxygen gradient in patients with community-acquired pneumonia ' (2010 ) 19 Heart Lung Circ. : 90 -92.

Mahmood N. A.Cardiac troponin I levels and alveolar-arterial oxygen gradient in patients with community-acquired pneumoniaHeart Lung Circ.2010199092)| false
• Search Google Scholar

ver Elst, K. M., Spapen, H. D., Nguyen, D. N., et al.: Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin. Chem., 2000, 46, 650–657.

Nguyen D. N. , 'Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock ' (2000 ) 46 Clin. Chem. : 650 -657.

Nguyen D. N.Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shockClin. Chem.200046650657)| false
• Search Google Scholar

Naghavi, M., Wyde, P., Litovsky, S., et al.: Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation, 2003, 107, 762–768.

Litovsky S. , 'Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice ' (2003 ) 107 Circulation : 762 -768.

Litovsky S.Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient miceCirculation2003107762768)| false
• Search Google Scholar

Ngeh, J., Anand, V., Gupta, S.: Chlamydia pneumoniae and atherosclerosis – what we know and what we don’t. Clin. Microbiol. Infect., 2002, 8, 2–13.

Gupta S. , 'Chlamydia pneumoniae and atherosclerosis – what we know and what we don’t ' (2002 ) 8 Clin. Microbiol. Infect. : 2 -13.

Gupta S.Chlamydia pneumoniae and atherosclerosis – what we know and what we don’tClin. Microbiol. Infect.20028213)| false
• Search Google Scholar

Grayston, J. T.: Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J. Infect. Dis., 2000, 181 (Suppl. 3), S402–S410.

Grayston J. T. , 'Background and current knowledge of Chlamydia pneumoniae and atherosclerosis ' (2000 ) 181 J. Infect. Dis. : S402 -S410.

Grayston J. T.Background and current knowledge of Chlamydia pneumoniae and atherosclerosisJ. Infect. Dis.2000181S402S410)| false
• Search Google Scholar

Crawford, V. L., McNerlan, S. E., Stout, R. W.: Seasonal changes in platelets, fibrinogen and factor VII in elderly people. Age Ageing, 2003, 32, 661–665.

Stout R. W. , 'Seasonal changes in platelets, fibrinogen and factor VII in elderly people ' (2003 ) 32 Age Ageing : 661 -665.

Stout R. W.Seasonal changes in platelets, fibrinogen and factor VII in elderly peopleAge Ageing200332661665)| false
• Search Google Scholar

Meier, C. R., Jick, S. S., Derby, L. E., et al.: Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet, 1998, 351, 1467–1471.

Derby L. E. , 'Acute respiratory-tract infections and risk of first-time acute myocardial infarction ' (1998 ) 351 Lancet : 1467 -1471.

Derby L. E.Acute respiratory-tract infections and risk of first-time acute myocardial infarctionLancet199835114671471)| false
• Search Google Scholar

Smeeth, L., Thomas, S. L., Hall, A. J., et al.: Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med., 2004, 351, 2611–2618.

Hall A. J. , 'Risk of myocardial infarction and stroke after acute infection or vaccination ' (2004 ) 351 N. Engl. J. Med. : 2611 -2618.

Hall A. J.Risk of myocardial infarction and stroke after acute infection or vaccinationN. Engl. J. Med.200435126112618)| false
• Search Google Scholar

Clayton, T. C., Thompson, M., Meade, T. W.: Recent respiratory infection and risk of cardiovascular disease: case control study through a general practice database. Eur. Heart J., 2008, 29, 96–103.

Meade T. W. , 'Recent respiratory infection and risk of cardiovascular disease: case control study through a general practice database ' (2008 ) 29 Eur. Heart J. : 96 -103.

Meade T. W.Recent respiratory infection and risk of cardiovascular disease: case control study through a general practice databaseEur. Heart J.20082996103)| false
• Search Google Scholar

Spodick, D. H., Flessas, A. P., Johnson, M. M.: Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am. J. Cardiol., 1984, 53, 481–482.

Johnson M. M. , 'Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients ' (1984 ) 53 Am. J. Cardiol. : 481 -482.

Johnson M. M.Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patientsAm. J. Cardiol.198453481482)| false
• Search Google Scholar

Syrjänen, J., Valtonen, V. V., Iivanainen, M., et al.: Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br. Med. J. (Clin. Res. Ed.), 1988, 296, 1156–1160.

Iivanainen M. , 'Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients ' (1988 ) 296 Br. Med. J. (Clin. Res. Ed.) : 1156 -1160.

Iivanainen M.Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patientsBr. Med. J. (Clin. Res. Ed.)198829611561160)| false
• Search Google Scholar

Lichtman, J. H., Fathi, A., Radford, M. J., et al.: Acute, severe noncardiac conditions in patients with acute myocardial infarction. Am. J. Med., 2006, 119, 843–850.

Radford M. J. , 'Acute, severe noncardiac conditions in patients with acute myocardial infarction ' (2006 ) 119 Am. J. Med. : 843 -850.

Radford M. J.Acute, severe noncardiac conditions in patients with acute myocardial infarctionAm. J. Med.2006119843850)| false
• Search Google Scholar

Musher, D. M., Rueda, A. M., Kaka, A. S., et al.: The association between pneumococcal pneumonia and acute cardiac events. Clin. Infect. Dis., 2007, 45, 158–165.

Kaka A. S. , 'The association between pneumococcal pneumonia and acute cardiac events ' (2007 ) 45 Clin. Infect. Dis. : 158 -165.

Kaka A. S.The association between pneumococcal pneumonia and acute cardiac eventsClin. Infect. Dis.200745158165)| false
• Search Google Scholar

Ramirez, J., Aliberti, S., Mirsaeidi, M., et al.: Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin. Infect. Dis., 2008, 47, 182–187.

Mirsaeidi M. , 'Acute myocardial infarction in hospitalized patients with community-acquired pneumonia ' (2008 ) 47 Clin. Infect. Dis. : 182 -187.

Mirsaeidi M.Acute myocardial infarction in hospitalized patients with community-acquired pneumoniaClin. Infect. Dis.200847182187)| false
• Search Google Scholar

Aliberti, S., Amir, A., Peyrani, P., et al.: Incidence, etiology, timing, and risk factors for clinical failure in hospitalised patients with community-acquired pneumonia. Chest, 2008, 134, 955–962.

Peyrani P. , 'Incidence, etiology, timing, and risk factors for clinical failure in hospitalised patients with community-acquired pneumonia ' (2008 ) 134 Chest : 955 -962.

Peyrani P.Incidence, etiology, timing, and risk factors for clinical failure in hospitalised patients with community-acquired pneumoniaChest2008134955962)| false
• Search Google Scholar

Corrales-Medina, V. F., Serpa, J., Rueda, A. M., et al.: Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine, 2009, 88, 154–159.

Rueda A. M. , 'Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes ' (2009 ) 88 Medicine : 154 -159.

Rueda A. M.Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromesMedicine200988154159)| false
• Search Google Scholar

Yende, S., Angus, D. C., Ali, I. S., et al.: Influence of comorbid conditions on long term mortality after pneumonia in older people. J. Am. Geriatr. Soc., 2007, 55, 518–525.

Ali I. S. , 'Influence of comorbid conditions on long term mortality after pneumonia in older people ' (2007 ) 55 J. Am. Geriatr. Soc. : 518 -525.

Ali I. S.Influence of comorbid conditions on long term mortality after pneumonia in older peopleJ. Am. Geriatr. Soc.200755518525)| false
• Search Google Scholar

Koivula, I., Stén, M., Mäkelä, P. H.: Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch. Intern. Med., 1999, 159, 1550–1555.

Mäkelä P. H. , 'Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study ' (1999 ) 159 Arch. Intern. Med. : 1550 -1555.

Mäkelä P. H.Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up studyArch. Intern. Med.199915915501555)| false
• Search Google Scholar

Naghavi, M., Barlas, Z., Siadaty, S., et al.: Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation, 2000, 102, 3039–3045.

Siadaty S. , 'Association of influenza vaccination and reduced risk of recurrent myocardial infarction ' (2000 ) 102 Circulation : 3039 -3045.

Siadaty S.Association of influenza vaccination and reduced risk of recurrent myocardial infarctionCirculation200010230393045)| false
• Search Google Scholar

Lamontagne, F., Garant, M. P., Carvalho, J. C., et al.: Pneumococcal vaccination and risk of myocardial infarction. CMAJ, 2008, 179, 773–777.

Carvalho J. C. , 'Pneumococcal vaccination and risk of myocardial infarction ' (2008 ) 179 CMAJ : 773 -777.

Carvalho J. C.Pneumococcal vaccination and risk of myocardial infarctionCMAJ2008179773777)| false
• Search Google Scholar

Tseng, H. F., Slezak, J. M., Quinn, V. P., et al.: Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA, 2010, 303, 1699–1706.

Quinn V. P. , 'Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men ' (2010 ) 303 JAMA : 1699 -1706.

Quinn V. P.Pneumococcal vaccination and risk of acute myocardial infarction and stroke in menJAMA201030316991706)| false
• Search Google Scholar